A B S T R A C T To evaluate the role of vitamin D in the physiologic response to phosphorus depletion (P depleton) and the response to vitamin D administration in P depletion, we studied vitamin D-deficient (-D) 
INTRODUCTION
With dietary phosphorus restriction and the appearance of phosphorus depletion, several physiologic events consistently occur: These include a marked reduction in urinary phosphorus excretion, the appearance of hypophosphatemia, hypercalciuria, and, in certain species, the development of hypercalcemia (1) (2) (3) (4) (5) . There is indirect evidence in animals (3, 6) and direct measurements in humans (7) suggesting that physiologic hypoparathyroidism develops during phosphate depletion. However, it has been shown that administration of parathyroid hormone does not modify renal phosphate conservation during phosphorus depletion (8, 9) and only partially reduces the hypercalciuria (3) .
It is now well established that interactions exist between phosphorus metabolism and the bioconversion and actions of vitamin D. Thus, the administration of 1,25-dihydroxy-vitamin D3 [1, 25(OH) 2D3]P enhances intestinal phosphorus transport in experimental ani-mals (10) and augments phosphorus absorption in man (11) . Moreover, there is potent phosphatemic action of 1,25-dihydroxy-vitamin D3 in hypophosphatemic animals as a result of phosphorus mobilization from bone (12, 13) . Furthermore, there is evidence that phosphorus depletion can stimulate the conversion of 25-hydroxyvitamin D3 to 1,25(OH)2D3 (14) . Thus, an important feedback mechanism may exist whereby phosphorus restriction alters the metabolism ofvitamin D, resulting in enhanced intestinal absorption ofphosphorus and its mobilization from bone. These events would act to maintain phosphorus homeostasis. The possibility that alterations in vitamin D metabolism and action may play an important role in the physiologic response to phosphorus depletion has not been thoroughly examined. In the present study, the physiologic response to phosphorus depletion was evaluated in animals that were either depleted of vitamin D or replaced with known amounts of vitamin D3 or specific quantities of 1,25(OH)2D3, the most active form of vitamin D.
METHODS
Weanling male Holtzman rats (Holtzman Co., Madison, Wis.) were fed an artifically prepared, vitamin D-deficient diet (15) containing 0.3% phosphorus and 0.5% calcium for 6 wk. At that time hypocalcemia was prominent (serum calcium, 1.70 +0.05 [SE] mM), and the animals weighed 140-160 g. The animals were then randomly separated into groups and housed in individual metabolic cages. 24-h urine samples were collected, and blood samples were obtained from the tail vein on alternate days. The animals were divided into two main groups: those receiving a low phosphorus (0.03%) diet (-P) and those receiving a normal phosphorus (0.3%) intake (+P). After the animals had received the vitamin D-deficient -P or +P diet for 3 days, each major group was then subdivided into four subgroups of 8-10 animals, each of which received either a vitamin D sterol or vehicle as indicated in Table I. The quantity of vitamin D3 given was that considered to be a normal replacement dose (16) , whereas the two levels of 1,25(OH)2D3 given were (a) near that needed for maintaining growth and serum calcium normal (low dose, LD), and (b) the quantity previously found to maximally stimulate intestinal calcium transport (high dose, HD).2 The vitamin D sterols or vehicle were injected intraperitoneally at the end of the 24-h urinary collections for days 3, 5, 7, and 8. The vitamin D3 was obtained from n.V. Phillips-Duphar (Weesp, The Netherlands), and the 1,25(OH)2D3 was provided by Dr. M. Uskokovic of Hoffmann-La Roche (Nutley, N. J.).
Food intake was measured daily, and the animals were weighed on each morning of injection. Although the animals were not pair-fed, there was no difference in dietary intake in any of the groups, except for the -P vitamin D-deficient (-D) group, which consumed less food only on days 4 and 5 (P < 0.05). The average daily food intake ranged from 9.0 to 11.0 g/d in the -P-D group, compared with 8.8 to 13.5 g/d in the -P groups, and 11.0 to 15.0 g/d in the +P groups. In no group was there a significant change in food intake from days 4 (17) and in urine utilizing a standard method previously reported (3). Serum urea nitrogen levels were measured in blood samples obtained on day 9 using the method of Siest et al. (18) . The statistical analysis involved one-way analysis of variance, the Dunnett's tests for multiple group comparison (19) , and multiple 'correlations carried out in a manner previously described (20) . All statistical comparisons of possible physiologic importance were made, but only the more pertinent P values are cited in the text.
RESULTS
Serial values of serum Pi in animals fed +P or -P diets are shown in Fig. 1 . In the animals receiving the normal phosphorus (P) intake, there was a significant phosphatemic effect in the groups receiving either dose of 1,25(OH)2D3, with mean serum Pi reaching levels of 3.25+0.05 mM and 3.82+0.06 mM after 24 h (day 4) in the 1,25LD and 1,25HD groups compared with 2.40 +0.06 mM in the -D group (P < 0.01). Serum Pi increased in the vitamin D-fed group (+ D) but to a lesser degree (P < 0.01 compared with 1,25LD and 1,25HD on day 4). After day 4, serum P remained stable in 1,25LD or even fell slightly in 1,25HD; the serum Pi rose to its maximal level, 4.10+-0.14 mM, on day 6 in the +D group.
In animals receiving the -P diet, serum Pi decreased substantially within 48 h after initiation of -P diet. By 24 h after administration of 1,25(OH)2D3, serum Pi increased prominently to 1.09+0.10 and 1.59+0.06 mM in 1,25LD and HD groups, respectively, compared with 0.08+0.012 mM in the -P animals (P < 0.01). Serum Pi remained low in vitamin D3-treated animals until the end of day 6 Table I . Each point represents mean+SEM in six to eight rats.
observed in the 1,25LD animals. Serum Pi was significantly higher in the 1,25HD, -P animals than in the other -P groups throughout the study (P < 0.01 at all times).
The values of serum Ca in animals given the +P and -P diets are shown in Fig. 2 . In the +P animals, serum Ca increased significantly to 2.20±0.050, 2.15 ±0.052, and 2.28+0.047 mM in +D, 1,25LD, and 1,25HD, respectively, by day 4, compared with a value of 1.0(4 ±0.051 mM in -D animals (P < 0.01). Serum Table I. Ca plateaued after day 6 in the +D animals, and there was a small but statistically significant further increase in the 1,25LD rats from 2.40±0.059 to 2.60±0.019 mM (P < 0.01). Serum Ca continued to increase in 1,25HD rats, reaching 3.15±0.062 mM on day 9.
In -P-D rats, serum Ca increased from 1.70±0.050 to 2.62+±0.055 mM by day 2 of P depletion (P < 0.01); thereafter, serum Ca was 2.49±0.068 mM on day 4 and 2.35±0.025 mM on day 9 (P = NS). In both 1,25LD and 1,25HD rats, serum Ca increased on day 4 within 24 h of treatment (P < 0.01); in the +D rats, serum Ca increased more slowly, and the difference between +D and -D did not become significant until day 6 (2.75±0.97 vs. 2.38±0.062, P < 0.01). For the 1,25HD and the 1,25LD groups, serum Ca did not show a significant change after day 4 . In comparing levels of serum Ca between the -P and +P animals, the values were all significantly greater in the -P rats (P < 0.01) except for the values obtained in the 1,25HD group on day 9.
Rates of urinary Pi excretion are shown in Fig. 3 for both +P and -P animals. Fig. 4 . In the rats receiving the +P diet, urinary Ca was low during the control period, with a mean value of0.89+0.003 mmol/mmol creatinine. There were no significant differences between urinary Ca in any +P group given any vitamin D sterol and the values in the -D+P group at any time of the study (P > 0.05).
In the -P rats, urinary Ca increased markedly within 24 h after initiation of the -P diet (P < 0.01), with a mean value of 1 The present studies demonstrate that marked hypercalciuria occurs during P depletion in the -D as well as the vitamin D3-treated animals. Hypocalciuria is very commonly found in vitamin D deficiency in man (22) ; however, the present data indicate that urinary Ca may be normal or even elevated when vitamin D deficiency and P depletion coexist in the rat. Metabolic acidosis occurs in -D rats (23) ; this factor could influence urinary Ca; however, hypercalciuria was not reversed by vitamin D itself, nor was it seen in the +P group. Hence, any contribution ofacidosis is speculative.
The initiation ofphosphate restriction was associated with a calcemic effect in the -D animal, and treatment with various vitamin D sterols raised serum Ca even further. It has been shown that P depletion, per se, does not lead to increased intestinal absorption of Ca in the -D rat (24) . Others found augmented release ofradiocalcium from bone during P depletion produced in vivo (13) and from bone maintained in organ culture and exposed to a reduced phosphate concentration (25 (26) .
The present data demonstrate a marked decrease in urinary Ca excretion in the P-depleted, hypercalciuric rat in response to treatment with 1,25(OH)2D3. This effect was observed during the first 24-h period after administration of 1,25(OH)2D3 and was greater in rats given the large dose of 1,25(OH)2D3 compared with those receiving the smaller dose. Serum Ca increased at the same time; thus, there probably was an increase in tubular reabsorption of Ca. Steele et al. (12) suggested that the fraction of filtered Ca excreted was reduced by 1,25(OH)2D3, and Costanzo et al. (27) found lower clearance ratios of Ca/Na in rats given a single dose of vitamin D3, 2.5 ,ug. Taken together, these data suggest that 1,25(OH)2D3 may enhance tubular Ca reabsorption when given to -D animals. However, there was an increase in serum Pi with the administration of the vitamin D sterol, and an inverse relationship existed between urinary Ca and serum Pi for all animals studied. An inverse relationship between serum Pi and urinary Ca has been previously noted in P-depleted dogs and rats (3, 12, 26) , and it is possible that the alterations in serum Pi were responsible for the changes in urinary Ca observed during treatment with the vitamin D sterols. Steele et al. (12) found that the infusion of phosphate to -D rats previously fed either 0.03 or 0.1% P was associated with a substantial decrease in urinary Ca. On the other hand, studies by Rizzoli et al. (28) demonstrated that urinary Ca increased in response to the administration of 11 ngld of 1,25-(OH)2D3. Moreover, the administration of 1,25(OH)2D3 to normal humans has generally produced an increase in urinary Ca, although this may occur because of a small increase in filtered Ca (29, 30) . Thus, the action of 1,25(OH)2D3 may vary, depending on the Ca needs or stores of the organism.
The results of the present studies indicate that the administration 1,25(OH)2D3 in only moderate doses can reduce urinary Pi excretion in -D rats receiving a +P diet. This was evident by the 2nd d of 1,25(OH)2D3 administration (day 5) in the 1,25HD group and on day 6 in the 1,25LD group. These effects occurred earlier than observed in the vitamin D3-treated rats. Also, urinary Pi excretion was lower in the 1,25LD or 1,25HD groups for any given level of serum Pi. Popovtzer et al. (31) and Puschett et al. (32) both reported an antiphosphaturic action of 25(OH)D3 in rats that was dependent upon the presence of parathyroid hormone (PTH). The quantities of 25(OH)D3 utilized in their studies were considerably greater than the amount of vitamin D3 given here and much greater than the amount of 1,25(OH)2D3 employed. Costanzo et al. (27) found that a large dose of vitamin D3, 2.5 ,ug, reduced urinary Pi excretion 48 h later in -D rats. The present results indicate that 1,25(OH)2D3, in a quantity only 2.5 times greater than that described by Bonjour et con- sidered. Only in the -P-D rats was food intake slightly lower than in the other groups; despite this, hypercalVitamin D and Phosphorus Depletion ciuria was most marked in this group. Also, there was no significant day-to-day differences in food intake for any group. Thus, altered dietary intake could not account for the changes in urinary excretion. The possibility that decreased renal function may have contributed to the fall in urinary Ca and decrease in urinary P in the 1,25HD groups exists, and the serum urea nitrogen levels were slightly increased. Parallel studies carried out in our laboratory indicate that decreased renal function and nephrocalcinosis do not occur in rats treated with 1,25(OH)2D3 until hypercalcemia supervenes (35) .3 Moreover, the fall in urinary Ca in the -P+1,25HD rats occurred as soon as day 4, and the urinary Pi fell in the +P+1,25HD group by day 5; on the other hand, the hypercalcemia only appeared on day 9 in the 1,25HD groups. The serum urea nitrogen was not increased in the + 1,25LD or + D groups, which also exhibited a fall in urinary Pi and Ca. Thus, we believe it unlikely that a decrease in renal function occurred early in the + 1,25HD groups when the most pronounced effect on urinary Ca and Pi were seen.
Observations of serial changes in serum Ca and Pi and urinary Ca in the -P rats and of sequential alterations in urinary Pi and serum Pi in the +P rats indicate an earlier effect of 1,25(OH)2D3 with both the "low" and "high" dose than observed with vitamin D3. These findings were unexpected because the conversion of vitamin D3 to 25(OH)D3 and then to 1,25-(OH)2D3 should proceed rapidly and effectively in rats with vitamin D deficiency, secondary hyperparathyroidism, and, in certain groups, P depletion as well (14) . This "delayed" effect of vitamin D3 ws observed with the administration of a quantity of vitamin D3 was observed with the administration of a quantity of vitamin D3 shown to be highly effective in healing rickets and promoting growth (16) . The reasons for the more rapid appearance of action of 1,25(OH)2D3 are not known, but at least two explanations may be considered. It is possible that 54 ng of 1,25(OH)2D3, given on alternate days, exceeds the maximal capacity for renal production ofthis sterol. However, this amount is only 2.5 times the quantity of 1,25(OH)2D3 that can restore Ca absorption to normal in parathyroidectomized rats (27) . The conversion of only 4% of the administered vitamin D3 to 1, 25 
